Category: Uncategorized

LEAD Coalition Builds Momentum for Expanded Research, Care and Support Funding

On the eve of action on the Health-Education-Labor Appropriations bill, LEAD Coalition executive director reiterated to Senate appropriators the urgency to provide at least the $100 million in additional funding for Alzheimer’s disease and related disorders as set forth in the President’s FY 2014 budget proposal. Read the July 8 letter.

LEAD Coalition Calls on Congress to Increase Research, Care and Support Appropriations

Sixty LEAD Coalition member organizations and supporters wrote to the U.S. House and Senate appropriations leadership in support of the Administration’s fiscal year 2014 budget proposal to provide an additional $80 million for Alzheimer’s disease and related disorders research at the National Institutes of Health and an additional $20 million to the Administration on Community […]

LEAD Coalition Urges CMS to Approve PET Amyloid Imaging

Thirty-seven LEAD Coalition member organizations and supporters wrote to the Centers for Medicare and Medicaid Services (CMS) to encourage issuance of a National Coverage Decision with immediate effect for PET amyloid imaging in the evaluation of progressive cognitive decline when its use follows the appropriate use criteria (AUC) developed by the Alzheimer’s Association and Society […]

LEAD Coalition Comments on FDA Draft Guidance for Development of Drugs for Early Stage Alzheimer’s Disease

Forty-seven LEAD Coalition member organizations and supporters joined together to submit formal comment welcoming the U.S. Food and Drug Administration (FDA) draft guidance which outlines FDA’s current thinking as to how to a drug developer may demonstrate efficacy in clinical trials in patients in the early stages of Alzheimer’s disease that occur before the onset of overt dementia. Read more…